Hjem › Lupus › Californien

Lupus kliniske forsøg i Californien

27 studier for Lupus søger deltagere på steder i Californien.

Byer i Californien

Officiel studietekst (engelsk)

A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

Sl0044 50737, Beverly Hills
Sl0044 50775, Beverly Hills
Sl0044 50257, La Jolla
og 6 flere

RekruttererFase 3

Alder 16 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT06617325

Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V

Ronald Reagan UCLA Medical Center, Los Angeles

RekruttererFase 2

Alder 18 til 100 · Alle køn · Opdateret 1. okt. 2026 · NCT05268289

A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)

Wallace & Lee Center, Beverly Hills
Arthritis & Osteoporosis Medical Center, Inc - La Palma, La Palma
University of California San Diego, San Diego
og 3 flere

RekruttererFase 2

Alder 18 til 74 · Alle køn · Opdateret 1. okt. 2026 · NCT07409181

Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).

Providence Medical Center, Burbank
Advanced Medical Research, La Palma

RekruttererFase 3

Alder 12 til 100 · Alle køn · Opdateret 1. okt. 2026 · NCT06133972

An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants

Research Site, Los Angeles

RekruttererFase 3

Alder 5 til 17 · Alle køn · Opdateret 30. sep. 2026 · NCT05835310

A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus

Research Site, Fontana
Research Site, La Jolla
Research Site, La Palma
og 3 flere

RekruttererFase 3

Alder 18 til 70 · Alle køn · Opdateret 25. sep. 2026 · NCT07430306

A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus

David S Hallegua MD A Professional Corporation, Beverly Hills
Providence Medical Foundation, Fullerton
Southland Arthritis and Osteoporosis Medical Center Inc dba Southland Arthritis, Hemet
og 5 flere

RekruttererFase 3

Alder 18 til 75 · Alle køn · Opdateret 25. sep. 2026 · NCT07438496

A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)

Solace Research /ID# 279155, Tustin

RekruttererFase 1

Alder 18 til 75 · Alle køn · Opdateret 25. sep. 2026 · NCT07607964

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

University of California Davis Comprehensive Cancer Center, Sacramento

RekruttererFase 1

Alder 18 og opefter · Alle køn · Opdateret 23. sep. 2026 · NCT03816345

Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants

Research Site, Fullerton

RekruttererFase 1

Alder 18 til 65 · Alle køn · Opdateret 18. sep. 2026 · NCT07201558

A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.

Research Site, La Jolla
Research Site, Sacramento

RekruttererFase 1

Alder 18 til 70 · Alle køn · Opdateret 15. sep. 2026 · NCT06916806

Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis

University of California San Francisco - Zuckerberg San Francisco General, San Francisco

RekruttererFase 1

Alder 18 til 60 · Alle køn · Opdateret 14. sep. 2026 · NCT06975787

A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)

Inland Rheumatology Clinical Trials, Inc., Upland

RekruttererFase 3

Alder 18 til 75 · Alle køn · Opdateret 14. sep. 2026 · NCT07355218

A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis

Wallace Rheumatic Studies Center, Beverly Hills
Kaiser Permanente Fontana, Fontana
Providence Medical Foundation, Fullerton
og 2 flere

RekruttererFase 2

Alder 12 til 70 · Alle køn · Opdateret 14. sep. 2026 · NCT07570862

A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease

Dermatology Research Associates - 300204025, Los Angeles
Cohen Medical Centers, Thousand Oaks

RekruttererFase 3

Alder 18 til 75 · Alle køn · Opdateret 11. sep. 2026 · NCT07332481

A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE

Research Site, San Francisco
Research Site, Stanford

RekruttererFase 1/2

Alder 18 til 70 · Alle køn · Opdateret 10. sep. 2026 · NCT06897930

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

Loma Linda University Medical Center, Loma Linda

RekruttererFase 1

Alder 18 til 74 · Alle køn · Opdateret 10. sep. 2026 · NCT07085104

A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants

Local Institution - 0054, La Jolla
Local Institution - 0001, La Palma
Local Institution - 0071, Los Angeles
og 1 flere

RekruttererObservationsstudie

Alder 16 og opefter · Alle køn · Opdateret 3. sep. 2026 · NCT07175285

FT839 in Autoimmune Diseases

Providence Medical Foundation, Fullerton

RekruttererFase 1/2

Alder 18 til 70 · Alle køn · Opdateret 2. sep. 2026 · NCT07800871

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

UC San Diego Health, La Jolla
Stanford University Medical Center, Redwood City

RekruttererFase 1

Alder 18 til 70 · Alle køn · Opdateret 28. aug. 2026 · NCT06925542

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

University of California Irvine, Orange
UC Davis Health, Sacramento

RekruttererFase 1/2

Alder 18 til 65 · Alle køn · Opdateret 26. aug. 2026 · NCT06121297

Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease

University of California, Los Angeles, Los Angeles
University of California: San Diego, San Diego

RekruttererFase 3

Alder 55 og opefter · Alle køn · Opdateret 20. aug. 2026 · NCT05799378

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus

Investigative Site, Beverly Hills

RekruttererFase 2

Alder 18 til 80 · Alle køn · Opdateret 27. jul. 2026 · NCT07260877

Phase 1a/b Tolerability of NTR-1011 in Healthy Adults and Adult Patients With SLE and RA

Carewell Arthritis Center, Apple Valley
Attune Health Research Inc, Beverly Hills
Covina Arthritis Clinic, Covina
og 4 flere

RekruttererFase 1

Alder 18 til 75 · Alle køn · Opdateret 20. jul. 2026 · NCT07237659

A Phase 1/2a Study of DB-2304 in Healthy Adults and SLE/CLE Participants

US06-0, La Palma

RekruttererFase 1/2Frivillige med god helbredstilstand velkomne

Alder 18 til 70 · Alle køn · Opdateret 2. jun. 2026 · NCT06625671

A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease

Wallace Rheumatic Center, Beverly Hills
Providence Medical Foundation, Fullerton
University of California Irvine, Irvine
og 2 flere

RekruttererFase 1

Alder 12 til 70 · Alle køn · Opdateret 22. maj 2026 · NCT06308978

Lupus Landmark Study: A Prospective Registry and Biorepository

Wallace Rheumatic Studies Center, Beverly Hills
UCLA, Los Angeles

RekruttererObservationsstudie

Alder 18 til 110 · Alle køn · Opdateret 15. apr. 2026 · NCT05934149

Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.